77/100BAlcon financials
On 30 June 2026 Alcon held 1.46B USD in cash and short-term investments against total debt of 5.30B USD. Its current ratio is 2.09: what falls due within a year against what turns into cash within a year. Over the last twelve months it generated 1.68B USD of free cash flow.
- Revenue (TTM)
- 10.81B USD
- Free cash flow (TTM)
- 1.68B USD
- Cash and short-term investments
- 1.46B USD
- Total debt
- 5.30B USD
- Shareholders' equity
- 21.60B USD
Cash, debt and equity as of 30 Jun 2026.
Alcon earnings
Revenue
EPS
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 0.94 | — | — | +20.58% | 2.84B | — | — | +7.90% | |
| Q3 FY2026 | 0.89 | — | — | +12.66% | 2.68B | — | — | +2.68% | |
| Q2 FY2026 | 0.77 | 0.84 | +9.09% | +10.53% | 2.72B | 2.79B | +2.54% | +7.48% | |
| Q1 FY2026 | 0.80 | 0.85 | +6.25% | +16.44% | 2.64B | 2.65B | +0.42% | +7.30% | |
| Q4 FY2025 | 0.79 | 0.78 | -1.27% | +8.33% | 2.69B | 2.64B | -1.87% | +5.35% | |
| Q3 FY2025 | 0.77 | 0.79 | +2.60% | -2.47% | 2.71B | 2.61B | -3.58% | +6.52% | |
| Q2 FY2025 | 0.71 | 0.76 | +7.04% | +2.70% | 2.65B | 2.60B | -2.06% | +3.38% | |
| Q1 FY2025 | 0.76 | 0.73 | -3.95% | -6.41% | 2.63B | 2.47B | -5.84% | +0.57% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 4.46 | — | — | +12.87% | 12.42B | — | — | +6.01% |
| FY2027 | 3.96 | — | — | +12.91% | 11.72B | — | — | +5.81% |
| FY2026 | 3.50 | — | — | +14.50% | 11.07B | — | — | +7.31% |
| FY2025 | 3.06 | 3.06 | -0.07% | +0.33% | 10.26B | 10.32B | +0.54% | +3.96% |
| FY2024 | 2.99 | 3.05 | +1.93% | +11.31% | 9.76B | 9.93B | +1.67% | +3.60% |
| FY2023 | 2.81 | 2.74 | -2.45% | +22.87% | 9.71B | 9.58B | -1.29% | +9.92% |
| FY2022 | 2.27 | 2.23 | -1.61% | +3.72% | 8.75B | 8.72B | -0.42% | +5.14% |
Alcon growth and profitability
Full income statement- Revenue (TTM)
- 10.81B USD
- Net income (TTM)
- 639.33M USD
- Gross margin
- 56.45%
- Operating margin
- 9.87%
- Net margin
- 5.92%
Revenue / Net income
How Alcon makes its money
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.
Alcon revenue breakdown
By region
| Region | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| International Geographic Areas | 5.66B | 35.4% | +6.3% |
| United States | 4.66B | 29.1% | +3.2% |
| Other Countries | 4.41B | 27.6% | +6.8% |
| Japan | 609.00M | 3.8% | +9.9% |
| China | 570.00M | 3.6% | +1.8% |
| Switzerland | 71.00M | 0.4% | -10.1% |
Operating and free cash flow
Full cash flow statementAlcon financial health
Full balance sheet- Cash and short-term investments
- 1.46B USD
- Total debt
- 5.30B USD
- Net cash
- -3.84B USD
- Free cash flow (TTM)
- 1.68B USD
- Current ratio
- 2.09
- Debt to equity
- 0.25
- Piotroski score
- 8 / 9
- Altman Z-score
- 2.95
Cash, debt and free cash flow
Assets, liabilities and equity
Alcon valuation
- Price to earnings ratio (TTM)
- 57.64
- Forward P/E (FY2026)
- 21.39
- Price to sales (TTM)
- 3.35
- Price to book
- 1.68
- EV / EBITDA (TTM)
- 14.47
Capital structure
Valuation over time
Alcon against its own history
Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.
Its peers: Centene, GE HealthCare Technologies, Biogen, Revolution Medicines, Medline, and Zoetis, the US Healthcare companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.
- P/E (today)Below its median57.635.7131.3
- Gross marginBelow its median55.2%54.5%56.1%Against its peers: 4 of 7Peers' median 55.2%
- Operating marginAbove its median13.1%7.0%14.3%Against its peers: 4 of 7Peers' median 10.6%
- Net marginAt its median9.4%3.8%10.3%Against its peers: 4 of 7Peers' median 7.1%
- Return on equityAt its median4.4%1.7%4.7%Against its peers: 5 of 7Peers' median 8.9%
- Free cash flow marginHighest in 5 years15.5%2.0%15.5%Against its peers: 3 of 7Peers' median 5.9%
- Revenue growthBelow its median4.9%4.8%21.3%Against its peers: 3 of 7Peers' median 3.6%
- EPS growthBelow its median-3.4%-10.5%188.2%Against its peers: 3 of 6Peers' median -5.9%
- Debt to EBITDABelow its median2.10×1.92×2.91×Against its peers: 1 of 5Peers' median 2.50×
- Current ratioBelow its median2.121.902.77Against its peers: 5 of 7Peers' median 2.85
Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.
Alcon dividends
- Annual dividend
- 0.36 USD
- Dividend yield (indicated)
- 0.48%
- Payout ratio
- 27.64%
- Years of dividend growth
- 5
- Frequency
- Annual
- Last payment
- 0.36 USD
- Last ex-dividend date
- 6 May 2026
- Last payment date
- 7 May 2026
Dividends per share
Alcon ownership
- Institutions
- 49.42%
- Institutional holders
- 671 (-19)
- Free float
- 99.68%
Who owns the shares
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Shares outstanding
Common questions about Alcon's financials
Source: Financial Modeling Prep